<VariationArchive RecordType="classified" VariationID="1119956" VariationName="NM_033198.4(PIGS):c.1141_1164dup (p.Asp381_Val388dup)" VariationType="Duplication" Accession="VCV001119956" Version="2" NumberOfSubmissions="1" NumberOfSubmitters="1" DateLastUpdated="2023-12-25" DateCreated="2021-05-23" MostRecentSubmission="2021-05-23">
  <RecordStatus>current</RecordStatus>
  <Species>Homo sapiens</Species>
  <ClassifiedRecord>
    <SimpleAllele AlleleID="1108697" VariationID="1119956">
      <GeneList>
        <Gene Symbol="PIGS" FullName="phosphatidylinositol glycan anchor biosynthesis class S" GeneID="94005" HGNC_ID="HGNC:14937" Source="submitted" RelationshipType="within single gene">
          <Location>
            <CytogeneticLocation>17q11.2</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="17" Accession="NC_000017.11" start="28553387" stop="28571524" display_start="28553387" display_stop="28571524" Strand="-" />
            <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="17" Accession="NC_000017.10" start="26880405" stop="26898886" display_start="26880405" display_stop="26898886" Strand="-" />
          </Location>
          <OMIM>610271</OMIM>
        </Gene>
      </GeneList>
      <Name>NM_033198.4(PIGS):c.1141_1164dup (p.Asp381_Val388dup)</Name>
      <CanonicalSPDI>NC_000017.11:28556182:CACCTCCATCACTCGCACCATGTCCACCTC:CACCTCCATCACTCGCACCATGTCCACCTCCATCACTCGCACCATGTCCACCTC</CanonicalSPDI>
      <VariantType>Duplication</VariantType>
      <Location>
        <CytogeneticLocation>17q11.2</CytogeneticLocation>
        <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" forDisplay="true" AssemblyStatus="current" Chr="17" Accession="NC_000017.11" start="28556182" stop="28556183" display_start="28556182" display_stop="28556183" variantLength="24" positionVCF="28556182" referenceAlleleVCF="A" alternateAlleleVCF="ACACCTCCATCACTCGCACCATGTC" />
        <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="17" Accession="NC_000017.10" start="26883200" stop="26883201" display_start="26883200" display_stop="26883201" variantLength="24" positionVCF="26883200" referenceAlleleVCF="A" alternateAlleleVCF="ACACCTCCATCACTCGCACCATGTC" />
      </Location>
      <OtherNameList>
        <Name>24-BP DUP, NT1141</Name>
      </OtherNameList>
      <HGVSlist>
        <HGVS Assembly="GRCh37" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000017.10" sequenceAccession="NC_000017" sequenceVersion="10" change="g.26883207_26883230dup" Assembly="GRCh37">
            <Expression>NC_000017.10:g.26883207_26883230dup</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Assembly="GRCh38" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000017.11" sequenceAccession="NC_000017" sequenceVersion="11" change="g.28556189_28556212dup" Assembly="GRCh38">
            <Expression>NC_000017.11:g.28556189_28556212dup</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="NG_012302.1" sequenceAccession="NG_012302" sequenceVersion="1" change="g.1423_1446dup">
            <Expression>NG_012302.1:g.1423_1446dup</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_033198.4" sequenceAccession="NM_033198" sequenceVersion="4" change="c.1141_1164dup" MANESelect="true">
            <Expression>NM_033198.4:c.1141_1164dup</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_149975.1" sequenceAccession="NP_149975" sequenceVersion="1" change="p.Asp381_Val388dup">
            <Expression>NP_149975.1:p.Asp381_Val388dup</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001821" Type="inframe_insertion" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_033198.4" sequenceAccession="NM_033198" sequenceVersion="4" change="c.1141_1164dup24" MANESelect="true">
            <Expression>NM_033198.4:c.1141_1164dup24</Expression>
          </NucleotideExpression>
          <MolecularConsequence ID="SO:0001821" Type="inframe_insertion" DB="SO" />
        </HGVS>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="LRG_341" sequenceAccession="LRG_341">
            <Expression>LRG_341:g.1423_1446dup</Expression>
          </NucleotideExpression>
        </HGVS>
      </HGVSlist>
      <XRefList>
        <XRef Type="Allelic variant" ID="610271.0009" DB="OMIM" />
        <XRef Type="rs" ID="769890071" DB="dbSNP" />
      </XRefList>
    </SimpleAllele>
    <RCVList>
      <RCVAccession Title="NM_033198.4(PIGS):c.1141_1164dup (p.Asp381_Val388dup) AND Glycosylphosphatidylinositol biosynthesis defect 18" Accession="RCV001449572" Version="2">
        <ClassifiedConditionList TraitSetID="44918">
          <ClassifiedCondition DB="MedGen" ID="C4748357">Glycosylphosphatidylinositol biosynthesis defect 18</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>no assertion criteria provided</ReviewStatus>
            <Description DateLastEvaluated="2021-05-22" SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
    </RCVList>
    <Classifications>
      <GermlineClassification DateLastEvaluated="2021-05-22" NumberOfSubmissions="1" NumberOfSubmitters="1" DateCreated="2021-05-23" MostRecentSubmission="2021-05-23">
        <ReviewStatus>no assertion criteria provided</ReviewStatus>
        <Description>Pathogenic</Description>
        <Citation Type="general">
          <ID Source="PubMed">33410539</ID>
        </Citation>
        <ConditionList>
          <TraitSet ID="44918" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="40716" Type="Disease">
              <Name>
                <ElementValue Type="Alternate">DEVELOPMENTAL AND EPILEPTIC ENCEPHALOPATHY 95</ElementValue>
                <XRef Type="MIM" ID="618143" DB="OMIM" />
                <XRef Type="Allelic variant" ID="610271.0002" DB="OMIM" />
                <XRef Type="Allelic variant" ID="610271.0005" DB="OMIM" />
                <XRef Type="Allelic variant" ID="610271.0004" DB="OMIM" />
                <XRef Type="Allelic variant" ID="610271.0007" DB="OMIM" />
                <XRef Type="Allelic variant" ID="610271.0001" DB="OMIM" />
                <XRef Type="Allelic variant" ID="610271.0008" DB="OMIM" />
                <XRef Type="Allelic variant" ID="610271.0003" DB="OMIM" />
                <XRef Type="Allelic variant" ID="610271.0006" DB="OMIM" />
                <XRef Type="Allelic variant" ID="610271.0009" DB="OMIM" />
                <XRef Type="Allelic variant" ID="610271.0010" DB="OMIM" />
              </Name>
              <Name>
                <ElementValue Type="Preferred">Glycosylphosphatidylinositol biosynthesis defect 18</ElementValue>
                <XRef ID="MONDO:0029140" DB="MONDO" />
              </Name>
              <Symbol>
                <ElementValue Type="Alternate">DEE95</ElementValue>
                <XRef Type="MIM" ID="618143" DB="OMIM" />
              </Symbol>
              <Symbol>
                <ElementValue Type="Alternate">GPIBD18</ElementValue>
                <XRef Type="MIM" ID="618143" DB="OMIM" />
              </Symbol>
              <XRef ID="C4748357" DB="MedGen" />
              <XRef ID="MONDO:0029140" DB="MONDO" />
              <XRef Type="MIM" ID="618143" DB="OMIM" />
            </Trait>
          </TraitSet>
        </ConditionList>
      </GermlineClassification>
    </Classifications>
    <ClinicalAssertionList>
      <ClinicalAssertion ID="3224944" SubmissionDate="2021-05-22" DateLastUpdated="2021-05-23" DateCreated="2021-05-23">
        <ClinVarSubmissionID localKey="610271.0009_DEVELOPMENTAL AND EPILEPTIC ENCEPHALOPATHY 95" title="PIGS, 24-BP DUP, NT1141_DEVELOPMENTAL AND EPILEPTIC ENCEPHALOPATHY 95" />
        <ClinVarAccession Accession="SCV001652688" DateUpdated="2021-05-23" DateCreated="2021-05-23" Type="SCV" Version="1" SubmitterName="OMIM" OrgID="3" OrganizationCategory="resource" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2021-05-22">
          <ReviewStatus>no assertion criteria provided</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species>human</Species>
              <AffectedStatus>not provided</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>literature only</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">In a Chinese patient (patient 6, family 5) with developmental and epileptic encephalopathy-95 (DEE95; 618143), Efthymiou et al. (2021) identified compound heterozygous mutations in the PIGS gene: a paternally inherited 24-bp duplication (c.1141_1164dup24, NM_033198.4) in exon 10, predicted to result in an in-frame insertion of 8 amino acids (Asp381_Val388dup), and a maternally inherited c.734G-A transition in exon 7, predicted to result in a trp245-to-ter (W245X; 610271.0010) substitution. The mutations, which were identified by trio whole-exome sequencing, segregated with the disorder in the family. The Asp381_Val388dup mutation was reported at an allele frequency of 0.029% in the East Asian population in the gnomAD database (v3). The W245X substitution was reported at an allele frequency of 0.0115% in the East Asian population in the gnomAD database (v.3). Testing in patient blood cells showed low CD14 in monocytes and FLAER in lymphocytes, consistent with reduced amounts of GPI-anchored proteins at the cell surface.</Attribute>
              <Citation>
                <ID Source="PubMed">33410539</ID>
              </Citation>
              <XRef DB="OMIM" ID="618143" Type="MIM" />
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="PIGS" />
          </GeneList>
          <Name>PIGS, 24-BP DUP, NT1141</Name>
          <VariantType>Variation</VariantType>
          <OtherNameList>
            <Name Type="NonHGVS">24-BP DUP, NT1141</Name>
          </OtherNameList>
          <XRefList>
            <XRef DB="OMIM" ID="610271.0009" Type="Allelic variant" />
          </XRefList>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <Name>
              <ElementValue Type="Preferred">DEVELOPMENTAL AND EPILEPTIC ENCEPHALOPATHY 95</ElementValue>
            </Name>
          </Trait>
        </TraitSet>
      </ClinicalAssertion>
    </ClinicalAssertionList>
    <TraitMappingList>
      <TraitMapping ClinicalAssertionID="3224944" TraitType="Disease" MappingType="Name" MappingValue="DEVELOPMENTAL AND EPILEPTIC ENCEPHALOPATHY 95" MappingRef="Preferred">
        <MedGen CUI="C4748357" Name="Glycosylphosphatidylinositol biosynthesis defect 18" />
      </TraitMapping>
    </TraitMappingList>
  </ClassifiedRecord>
</VariationArchive>

